Christine P Carney
Overview
Explore the profile of Christine P Carney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carney C, Pandey N, Kapur A, Saadi H, Ong H, Chen C, et al.
ACS Nano
. 2023 Oct;
17(20):19667-19684.
PMID: 37812740
The TWEAK receptor, Fn14, is a promising candidate for active targeting of cancer nanotherapeutics to many solid tumor types, including metastatic breast and primary brain cancers. Targeting of therapeutic nanoparticles...
2.
Carney C, Kapur A, Anastasiadis P, Ritzel R, Chen C, Woodworth G, et al.
Mol Pharm
. 2022 Nov;
20(1):314-330.
PMID: 36374573
Triple-negative breast cancer (TNBC) patients with brain metastasis (BM) face dismal prognosis due to the limited therapeutic efficacy of the currently available treatment options. We previously demonstrated that paclitaxel-loaded PLGA-PEG...
3.
Pandey N, Anastasiadis P, Carney C, Kanvinde P, Woodworth G, Winkles J, et al.
Adv Drug Deliv Rev
. 2022 Jul;
188:114415.
PMID: 35787387
Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to the brain-invading tumor cells...
4.
Carney C, Pandey N, Kapur A, Woodworth G, Winkles J, Kim A
Drug Deliv Transl Res
. 2021 Oct;
11(6):2344-2370.
PMID: 34716900
Brain metastases (BMs) are the most common type of brain tumor, and the incidence among breast cancer (BC) patients has been steadily increasing over the past two decades. Indeed, ~ ...
5.
Wadajkar A, Dancy J, Carney C, Hampton B, Ames H, Winkles J, et al.
Nanomedicine
. 2019 Jun;
20:102024.
PMID: 31176045
Therapeutic efficacy of nanoparticle-drug formulations for cancer applications is significantly impacted by the extent of intra-tumoral accumulation and tumor tissue penetration. We advanced the application of surface plasmon resonance to...